Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Revenue: 2012-2024

Historic Revenue for Neurogene (NGNE) over the last 10 years, with Dec 2024 value amounting to $925,000.

  • Neurogene's Revenue fell 121.05% to -$42,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$610,000, marking a year-over-year increase of 47.91%. This contributed to the annual value of $925,000 for FY2024, which is 3403.57% up from last year.
  • Per Neurogene's latest filing, its Revenue stood at $925,000 for FY2024, which was up 3,403.57% from -$28,000 recorded in FY2023.
  • Neurogene's 5-year Revenue high stood at $925,000 for FY2024, and its period low was -$28,000 during FY2023.
  • Its 3-year average for Revenue is $296,667, with a median of -$7,000 in 2022.
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 300.00% in 2023, then soared by 3,403.57% in 2024.
  • Yearly analysis of 3 years shows Neurogene's Revenue stood at -$7,000 in 2022, then tumbled by 300.00% to -$28,000 in 2023, then surged by 3,403.57% to $925,000 in 2024.